Chemical-Defined GMP Biopreservation Media
Total Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
332
NCT05335980
Nu-V3 Non-Invasive Nerve Stimulation Device Trial for Chronic Pain, Anxiety, Depression, Sleeplessness
Phase: N/A
Role: Lead Sponsor
Start: Apr 13, 2018
Completion: Dec 31, 2020
NCT04059107
Prosthetic Device in Children With Upper Congenital Limb Deficiency
Role: Collaborator
Start: Jul 3, 2019
Completion: Dec 31, 2021
NCT04202627
Biomarker Development in LGMD2i
Start: Dec 1, 2019
Completion: Oct 10, 2022
NCT04800874
Study of BBP-418 in Patients With LGMD2I
Phase: Phase 2
Start: Feb 18, 2021
Completion: Nov 1, 2026
NCT05547308
Evaluation of 3D Printed Myoelectric Prosthetic Devices in Children With Upper Congenital Limb Deficiency
Start: Nov 30, 2022
Completion: Nov 30, 2027
NCT05775848
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
Phase: Phase 3
Start: May 31, 2023
Completion: Jul 31, 2027
NCT05394545
Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness
Start: Mar 20, 2024
Completion: May 31, 2025
Loading map...